GLP-3(RT)

Description

GLP-3(RT) is a synthetic triple agonist of the GLP-1, GIP, and glucagon receptors, supplied as a lyophilized powder for in-vitro research. It is studied in laboratory models of incretin signaling, hepatic lipid handling, and energy metabolism. Sold strictly for research use, not for human or veterinary use.

Storage & handling

Store lyophilized vials at -20 °C, protected from light and moisture. Keep sealed until use and avoid repeated freeze–thaw cycles. Handle per your laboratory's standard operating procedures.

Research applications

• Triple-receptor (GLP-1R / GIPR / GCGR) binding and selectivity assays
• Comparative pharmacology against dual- and single-agonist incretin peptides
• Metabolic and hepatic lipid-handling research models

Sold strictly for in-vitro laboratory research. Not for human or veterinary use, diagnosis, treatment, or consumption.

Research status

Where the published evidence stands for each active compound, with the primary source. Regulatory standing is listed for context only. Nothing sold here is approved for human use.

• GLP-3(RT)Phase 3

  In late-stage clinical development for metabolic indications, with Phase 3 studies registered on ClinicalTrials.gov. Not approved by the FDA for any use.

  ClinicalTrials.gov NCT04881760 ↗